Related Experiment Videos
Tetrahydroaminoacridine attenuates dizocilpine-induced behavioural changes
1University of Tübingen, Zoological Institute, Neuropharmacology Division, FRG.
Behavioural Brain Research
|February 26, 1993
Summary
Tetrahydroaminoacridine (THA) reversed behavioral changes caused by the NMDA antagonist dizocilpine in rats. THA mitigated dizocilpine-induced hyperactivity and spatial learning deficits, suggesting a functional glutamate agonism.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Tetrahydroaminoacridine (THA), an acetylcholinesterase inhibitor, interacts with non-cholinergic neurotransmitter systems.
- Previous research indicates THA interacts with the N-methyl-D-aspartate (NMDA) receptor, a subtype of the glutamatergic system.
Purpose of the Study:
- To investigate if THA alters behavioral changes induced by dizocilpine, a non-competitive NMDA receptor antagonist.
- To explore the potential functional glutamate agonism of THA.
Main Methods:
- Behavioral assessments in rats, including spontaneous locomotion in an open field.
- Evaluation of learning behavior using a spatial learning task in an 8-arm radial maze.
- Administration of dizocilpine and THA at varying doses to assess their effects on behavior.
Main Results:
- THA (5 mg/kg) reversed dizocilpine-induced hyperactivity at 0.08 mg/kg.
- THA (2.5 mg/kg and 5 mg/kg) reversed hyperactivity induced by 0.16 mg/kg dizocilpine.
- THA (2.5 mg/kg) attenuated dizocilpine-induced spatial learning deficits in the 8-arm radial maze by the 6th and 7th day of testing.
Conclusions:
- THA demonstrates the ability to counteract behavioral disruptions caused by NMDA receptor antagonism.
- The findings support the hypothesis of a functional glutamate agonism of THA.
- THA may have therapeutic implications for conditions involving NMDA receptor dysfunction.